Clinical laboratories are under increasing pressure from three sources: reimbursement, regulatory, and resource. Reimbursement is the most pressing issue for many labs: whether in a fully-bundled, ...

DEXIS (TM), a global leader in digital diagnostic imaging and intraoral scanning solutions, today announced significant advancements to its lab-to-clinic workflow solutions during a week of key ...

The global laboratory automation market is projected to grow at a CAGR of approximately 7% over the forecast period. Growth is being fueled by the increasing integration of automation, artificial ...

This new laboratory workflow aims to combine both companies’ technologies to deliver AI-ready automation that can scale with ...

In a recent advisory opinion, the Office of Inspector General ruled a specific urgent care management service organization’s plan to run an affiliated clinical lab would not create prohibited ...

TUCSON, Ariz., Oct. 27, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today a first-of-its-kind integration of the VIRTUOSO digital pathology ...

Increased patient testing and less lab staff to perform manual tasks have created a bottleneck for care Now, automation found in high-volume labs is accessible no matter a lab’s footprint or volume ...

Ultima Genomics, a developer of ultra-high-throughput sequencing systems, together with Hamilton (Hamilton Company and Hamilton Bonaduz AG), a global leader in precision laboratory automation, today ...

Research shows that 77 percent of lab professionals now use public AI tools alongside their ELN. For many, this is not driven by policy decisions, but by necessity. Governed tools do not yet support ...

Ultima Genomics, Hamilton partner to enable improved lab operations to drive sequencing at scale: Fremont, California Saturday, February 28, 2026, 11:00 Hrs [IST] Ultima Genomics, ...

Veteran laboratory executive to accelerate growth as demand rises for upstream revenue and order integrity solutions Labs can no longer afford to discover revenue problems after testing is already ...